Globalization of Biosimilars

Globalization of Biosimilars is about the generic drugs impact on Global Biosimilar market, Cost and risk management, adopting innovative mechanisms such as risk-sharing arrangement, European market for Biosimilars. A growing global market for Biosimilars is gaining momentum in response to the expiration of patents for a number of key biologics and consumer demand to reduce treatment costs. Thus, according to Research and Markets, the global biosimilar market, valued at $2 billion in 2012 is projected to reach $19.4 billion by 2018.

 

  • Global impact of Biosimilars over generics
  • Economic aspect towards Biosimilars
  • Biopharmaceuticals developmentBiosimilars in global market
  • Investment and returns on Biosimilars
  • Cost and risk management
  • Adopting innovative mechanisms such as risk-sharing arrangement
  • European market for Biosimilars
  • Global P&R models for the Biosimilars and generics market

Related Conference of Globalization of Biosimilars

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson Toronto Airport West, 175 Derry Road East, Mississauga, ON, L5T 2Z7, Canada
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15 | 2018

13th International Conference on Biosimilars and Biologics

Lisbon | Portugal

Globalization of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in